Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung

Completed · Phase 1 · Has a placebo group

Conditions studied: Mucociliary Clearance

In brief

The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.

Key facts

Study ID

NCT00902707

Run by

University of North Carolina, Chapel Hill

People needed

12

Starts

2009-05-01

Expected to finish

2012-05-01

Last updated by the study team

2012-06-11

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy
• Non smoker
• BMI 19-29
• Normal lung function

You may not qualify if…

• Pregnant
• Smokers
• Any illness

Where it is running

• UNC Center for Environmental Medicine, Asthma and Lung Biology — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.